Cyrille HULIN: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

Facon, Thierry, Kumar, Shaji, Plesner, Torben, Orlowski, Robert Z., Moreau, Philippe, Bahlis, Nizar, Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, O’Dwyer, Michael,

Journal:

New England Journal of Medicine

Year:

2019

Language:

english

File:

PDF, 310 KB

english, 2019

2

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Moreau, Philippe, Attal, Michel, Hulin, Cyrille, Arnulf, Bertrand, Belhadj, Karim, Benboubker, Lotfi, Béné, Marie C, Broijl, Annemiek, Caillon, Hélène, Caillot, Denis, Corre, Jill, Delforge, Michel, D

Journal:

Lancet (London, England)

Year:

2019

Language:

english

File:

PDF, 1.22 MB

english, 2019

3

Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

Attal, Michel, Lauwers-Cances, Valerie, Marit, Gerald, Caillot, Denis, Moreau, Philippe, Facon, Thierry, Stoppa, Anne Marie, Hulin, Cyrille, Benboubker, Lofti, Garderet, Laurent, Decaux, Olivier, Leyv

Journal:

Boston Medical and Surgical Journal

Year:

2012

Language:

english

File:

PDF, 542 KB

english, 2012

4

Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice

Terpos, Evangelos, Katodritou, Eirini, de la Rubia, Javier, Hungria, Vania, Hulin, Cyrille, Roussou, Maria, Delforge, Michel, Bries, Greet, Stoppa, Anne-Marie, Aagesen, Jesper, Sargin, Deniz, Belch, A

Journal:

European Journal of Haematology

Year:

2018

Language:

english

File:

PDF, 405 KB

english, 2018

5

Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTd) in Transplant-eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-risk Patients (Pts) in CASSIOPEIA

Sonneveld, Pieter, Attal, Michel, Perrot, Aurore, Hulin, Cyrille, Caillot, Denis, Facon, Thierry, Leleu, Xavier, Belhadj-Merzoug, Karim, Karlin, Lionel, Benboubker, Lofti, Levin, Mark-David, Minnema,

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

File:

PDF, 84 KB

2019

6

Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparison

Moreau, Philippe, Hebraud, Benjamin, Facon, Thierry, Leleu, Xavier, Hulin, Cyrille, Hashim, Mahmoud, Hu, Yannan, Caillot, Denis, Benboubker, Lofti, Zweegman, Sonja, Merz, Maximilian, Weisel, Katja, Sa

Journal:

Year:

2020

File:

PDF, 817 KB

2020

7

Frontline treatment of multiple myeloma in elderly patients

Philippe Moreau, Cyrille Hulin, Thierry Facon

Journal:

Year:

2008

Language:

english

File:

PDF, 110 KB

english, 2008

8

Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cells

Pierre Feugier, Daniele Bensoussan, Florence Girard, Francois Alla, Anne Schuhmacher, Veronique Latger-Cannard, Cyrille Hulin, Francis Witz, Brigitte Witz, Anne Sophie Carret, Pierre Bordigoni, Pierre

Journal:

Transfusion (Wiley)

Year:

2003

Language:

english

File:

PDF, 322 KB

english, 2003

9

Impact of free light chain hemodialysis in myeloma cast nephropathy: A case–control study

Nicolas O. PETERS, Emmanuelle LAURAIN, Joëlle CRIDLIG, Cyrille HULIN, Thanh CAO-HUU, Luc FRIMAT

Journal:

Hemodialysis International

Year:

2011

Language:

english

File:

PDF, 363 KB

english, 2011

10

Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome

Ibrahim Yakoub-Agha, Jean-Yves Mary, Cyrille Hulin, Chantal Doyen, Gérald Marit, Lotfi Benboubker, Laurent Voillat, Philippe Moreau, Christian Berthou, Anne-Marie Stoppa, Frédéric Maloisel, Philippe R

Journal:

European Journal of Haematology

Year:

2012

Language:

english

File:

PDF, 304 KB

english, 2012

11

Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial

Bertrand Godeau, Sylvie Chevret, Bruno Varet, François Lefrère, Jean-Marc Zini, François Bassompierre, Stéphane Chèze, Eric Legouffe, Cyrille Hulin, Marie-José Grange, Olivier Fain, Philippe Bierling

Journal:

Year:

2002

Language:

english

File:

PDF, 103 KB

english, 2002

12

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial

Thierry Facon, Jean Yves Mary, Cyrille Hulin, Lotfi Benboubker, Michel Attal, Brigitte Pegourie, Marc Renaud, Jean Luc Harousseau, Gaëlle Guillerm, Carine Chaleteix, Mamoun Dib, Laurent Voillat, Hervé

Journal:

Year:

2007

Language:

english

File:

PDF, 183 KB

english, 2007

13

Treatment for elderly patients with multiple myeloma – Authors' reply

Thierry Facon, Jean-Yves Mary, Cyrille Hulin, Lotfi Benboubker, Michel Attal

Journal:

Year:

2008

Language:

english

File:

PDF, 56 KB

english, 2008

14

Frontline Treatment in Elderly Patients With Multiple Myeloma

Thierry Facon, Jesus San Miguel, Maria Victoria Mateos, Cyrille Hulin

Journal:

Seminars in Hematology

Year:

2009

Language:

english

File:

PDF, 261 KB

english, 2009

15

Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma

Philippe Moreau, Ievgenii I. Karamanesht, Natalia Domnikova, Maryna Y. Kyselyova, Kateryna V. Vilchevska, Vadim A. Doronin, Alexander Schmidt, Cyrille Hulin, Xavier Leleu, Dixie-Lee Esseltine, Karthik

Journal:

Clinical Pharmacokinetics

Year:

2012

Language:

english

File:

PDF, 337 KB

english, 2012

16

Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

Attal, Michel, Harousseau, Jean-Luc, Facon, Thierry, Guilhot, François, Doyen, Chantal, Fuzibet, Jean-Gabriel, Monconduit, Mathieu, Hulin, Cyrille, Caillot, Denis, Bouabdallah, Reda, Voillat, Laurent,

Journal:

Boston Medical and Surgical Journal

Year:

2003

Language:

english

File:

PDF, 110 KB

english, 2003

17

Autologous Stem Cell Transplantation: An Effective Salvage Therapy in Multiple Myeloma

Lemieux, Emilie, Hulin, Cyrille, Caillot, Denis, Tardy, Stéphanie, Dorvaux, Véronique, Michel, Jessica, Gastinne, Thomas, Rossi, Cédric, Legouge, Caroline, Touzeau, Cyrille, Planche, Lucie, Loirat, Ma

Journal:

Biology of Blood and Marrow Transplantation

Year:

2013

Language:

english

File:

PDF, 247 KB

english, 2013

18

Frontline Therapy for Patients with Multiple Myeloma not Eligible for Stem Cell Transplantation

Moreau, Philippe, Hulin, Cyrille, Facon, Thierry

Journal:

Hematology/Oncology Clinics of North America

Year:

2014

Language:

english

File:

PDF, 183 KB

english, 2014

19

Toxoplasmosis in Kidney Transplant Recipients: Report of Six Cases and Review

Edith Renoult, Etienne Georges, Marie-France Biava, Cyrille Hulin, Luc Frimat, Dominique Hestin and Michèle Kessler

Journal:

Clinical Infectious Diseases

Year:

1997

Language:

english

File:

PDF, 765 KB

english, 1997

20

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma

Attal, Michel, Lauwers-Cances, Valerie, Hulin, Cyrille, Leleu, Xavier, Caillot, Denis, Escoffre, Martine, Arnulf, Bertrand, Macro, Margaret, Belhadj, Karim, Garderet, Laurent, Roussel, Murielle, Payen

Journal:

New England Journal of Medicine

Year:

2017

Language:

english

File:

PDF, 296 KB

english, 2017

21

Living with the burden of relapse in multiple myeloma from the patient and physician perspective

Hulin, Cyrille, Hansen, Timon, Heron, Louise, Pughe, Rachel, Streetly, Matthew, Plate, Ananda, Perkins, Sue, Morgan, Kate, Tinel, Antoine, Rodrigues, Filipe, Ramasamy, Karthik

Journal:

Leukemia Research

Year:

2017

Language:

english

File:

PDF, 1.49 MB

english, 2017

22

Lenalidomide (LEN) Maintenance Following High-Dose Melphalan and Autologous Stem Cell Transplant (ASCT) in Patients (Pts) With Newly Diagnosed Multiple Myeloma (MM): A Meta-Analysis of Overall Survival (OS)

McCarthy, Philip, Holstein, Sarah, Petrucci, Maria Teresa, Richardson, Paul, Hulin, Cyrille, Tosi, Patrizia, Bringhen, Sara, Musto, Pellegrino, Anderson, Kenneth C., Caillot, Denis, Gay, Francesca, Mo

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 63 KB

english, 2017

23

Hypocoagulability as assessed by thrombin generation test in newly-diagnosed patients with multiple myeloma

Legendre, Pauline, Verstraete, Emma, Martin, Michèle, Poinsard, Amélie, Perrot, Aurore, Hulin, Cyrille, Faure, Gilbert, Latger-Cannard, Véronique, Perrin, Julien

Journal:

Blood Cells, Molecules, and Diseases

Year:

2017

Language:

english

File:

PDF, 300 KB

english, 2017

24

Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma

Fouquet, Guillemette, Karlin, Lionel, Macro, Margaret, Caillot, Denis, Roussel, Murielle, Arnulf, Bertrand, Pegourie, Brigitte, Petillon, Marie Odile, Mathiot, Claire, Hulin, Cyrille, Kolb, Brigitte,

Journal:

Annals of Hematology

Year:

2018

Language:

english

File:

PDF, 770 KB

english, 2018

25

MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs

Leleu, Xavier, Rodon, Philippe, Hulin, Cyrille, Daley, Laurent, Dauriac, Charles, Hacini, Maya, Decaux, Olivier, Eisemann, Jean-Claude, Fitoussi, Olivier, Lioure, Bruno, Voillat, Laurent, Slama, Borha

Journal:

Thrombosis and Haemostasis

Year:

2013

Language:

english

File:

PDF, 622 KB

english, 2013

26

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial

Dumontet, Charles, Hulin, Cyrille, Dimopoulos, Meletios A., Belch, Andrew, Dispenzieri, Angela, Ludwig, Heinz, Rodon, Philippe, Van Droogenbroeck, Jan, Qiu, Lugui, Cavo, Michele, Van de Velde, Ann, La

Journal:

Year:

2018

Language:

english

File:

PDF, 1.05 MB

english, 2018

27

Interim PET analysis in first line therapy of multiple myeloma: Prognostic value of ΔSUVmax in the FDG-avid patients of the IMAJEM study

Bailly, Clement, Carlier, Thomas, Jamet, Bastien, Eugene, Thomas, Touzeau, Cyrille, Attal, Michel, Hulin, Cyrille, Facon, Thierry, Leleu, Xavier, Perrot, Aurore, Garderet, Laurent, Macro, Margaret, CA

Journal:

Clinical Cancer Research

Year:

2018

Language:

english

File:

PDF, 3.18 MB

english, 2018

28

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

Perrot, Aurore, Lauwers-Cances, Valerie, Corre, Jill, Robillard, Nelly, Hulin, Cyrille, Chretien, Marie-Lorraine, Dejoie, Thomas, Maheo, Sabrina, Stoppa, Anne-Marie, Pegourie, Brigitte, Karlin, Lionel

Journal:

Year:

2018

Language:

english

File:

PDF, 385 KB

english, 2018

29

Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow

Mazzotti, Céline, Buisson, Laure, Maheo, Sabrina, Perrot, Aurore, Chretien, Marie-Lorraine, Leleu, Xavier, Hulin, Cyrille, Manier, Salomon, Hébraud, Benjamin, Roussel, Murielle, Do Souto, Laura, Attal

Journal:

Year:

2018

Language:

english

File:

PDF, 650 KB

english, 2018

30

Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

McCarthy, Philip L., Holstein, Sarah A., Petrucci, Maria Teresa, Richardson, Paul G., Hulin, Cyrille, Tosi, Patrizia, Bringhen, Sara, Musto, Pellegrino, Anderson, Kenneth C., Caillot, Denis, Gay, Fran

Journal:

Journal of Clinical Oncology

Year:

2017

File:

PDF, 930 KB

2017

31

Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma

Perrot, Aurore, Lauwers-Cances, Valérie, Tournay, Elodie, Hulin, Cyrille, Chretien, Marie-Lorraine, Royer, Bruno, Dib, Mamoun, Decaux, Olivier, Jaccard, Arnaud, Belhadj, Karim, Brechignac, Sabine, Fon

Journal:

Journal of Clinical Oncology

Year:

2019

Language:

english

File:

PDF, 1.09 MB

english, 2019

32

Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma

Perrot, Aurore, Lauwers-Cances, Valérie, Tournay, Elodie, Hulin, Cyrille, Chretien, Marie-Lorraine, Royer, Bruno, Dib, Mamoun, Decaux, Olivier, Jaccard, Arnaud, Belhadj, Karim, Brechignac, Sabine, Fon

Journal:

Journal of Clinical Oncology

Year:

2019

File:

PDF, 1.09 MB

2019

33

Integrated Analysis of Bortezomib-Lenalidomide-Dexamethasone vs Bortezomib-Thalidomide-Dexamethasone in Transplant-Eligible Newly Diagnosed Myeloma

Rosinol, Laura, Hebraud, Benjamin, Oriol, Albert, Colin, Anne-Laurène, Tamayo, Rafael Ríos, Hulin, Cyrille, Blanchard, Maria Jesús, Caillot, Denis, Balari, Anna Sureda, Hernandez, Miguel T., Arnulf, B

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 94 KB

english, 2019

34

Subcutaneous (SC) Daratumumab (DARA) in Combination With Standard Multiple Myeloma (MM) Treatment Regimens: An Open-label, Multicenter Phase 2 Study (PLEIADES)

Chari, Ajai, Goldschmidt, Hartmut, San-Miguel, Jesus, McCarthy, Helen, Suzuki, Kenshi, Hungria, Vania, Balari, Anna Sureda, Perrot, Aurore, Hulin, Cyrille, Magen, Hila, Iida, Shinsuke, Maisnar, Vladim

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 84 KB

english, 2019

35

Integrated Analysis of Bortezomib-Lenalidomide-Dexamethasone vs Bortezomib-Thalidomide-Dexamethasone in Transplant-Eligible Newly Diagnosed Myeloma

Rosinol, Laura, Hebraud, Benjamin, Oriol, Albert, Colin, Anne-Laurène, Tamayo, Rafael Ríos, Hulin, Cyrille, Blanchard, Maria Jesús, Caillot, Denis, Balari, Anna Sureda, Hernandez, Miguel T., Arnulf, B

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

File:

PDF, 94 KB

2019

36

Subcutaneous (SC) Daratumumab (DARA) in Combination With Standard Multiple Myeloma (MM) Treatment Regimens: An Open-label, Multicenter Phase 2 Study (PLEIADES)

Chari, Ajai, Goldschmidt, Hartmut, San-Miguel, Jesus, McCarthy, Helen, Suzuki, Kenshi, Hungria, Vania, Balari, Anna Sureda, Perrot, Aurore, Hulin, Cyrille, Magen, Hila, Iida, Shinsuke, Maisnar, Vladim

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

File:

PDF, 84 KB

2019

37

Efficacy of isatuximab/pomalidomide/dexamethasone in relapsed/refractory multiple myeloma: ICARIA-MM high-risk cytogenetics subgroup analysis

Harrison, Simon J., Richardson, Paul G., Alegre, Adrian, Simpson, David, Wang, Ming Chung, Spencer, Andrew, Delimpasi, Sossana, Hulin, Cyrille, Sunami, Kazutaka, Facon, Thierry, Vlummens, Philip, Yong

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

File:

PDF, 67 KB

2019

38

A Matching-Adjusted Indirect Comparison (MAIC) of Daratumumab-Bortezomib-Thalidomide-Dexamethasone (D-VTd) Versus Bortezomib-Lenalidomide-Dexamethasone (VRd) in Patients (Pts) With Newly Diagnosed Multiple Myeloma (NDMM) who are Transplant Eligible

Moreau, Philippe, Attal, Michel, Facon, Thierry, Leleu, Xavier, Hulin, Cyrille, Hashim, Mahmoud, Hu, Yannan, Cote, Sarah, Kampfenkel, Tobias, de Boer, Carla, Lam, Annette, Sonneveld, Pieter

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

File:

PDF, 83 KB

2019

39

Health-related quality of life results from the IFM 2009 trial: treatment with lenalidomide, bortezomib, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma

Roussel, Murielle, Hebraud, Benjamin, Hulin, Cyrille, Perrot, Aurore, Caillot, Denis, Stoppa, Anne-Marie, Macro, Margaret, Escoffre, Martine, Arnulf, Bertrand, Belhadj, Karim, Karlin, Lionel, Garderet

Journal:

Leukemia and Lymphoma

Year:

2020

File:

PDF, 1.56 MB

2020

40

Stem Cell Factor in Combination With Filgrastim After Chemotherapy Improves Peripheral Blood Progenitor Cell Yield and Reduces Apheresis Requirements in Multiple Myeloma Patients: A Randomized, Controlled Trial

Facon, Thierry, Harousseau, Jean-Luc, Maloisel, FreÌdeÌric, Attal, Michel, Odriozola, Jesus, Alegre, Adrian, Schroyens, Wilfried, Hulin, Cyrille, Schots, Rik, Marin, Pedro, Guilhot, FrancÌ§ois, Gran

Journal:

Year:

1999

File:

PDF, 240 KB

1999

41

Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk

Corre, Jill, Montes, Lydia, Martin, Elodie, Perrot, Aurore, Caillot, Denis, Leleu, Xavier, Belhadj, Karim, Facon, Thierry, Hulin, Cyrille, Mohty, Mohamad, Fontan, Jean, Macro, Margaret, Brechignac, Sa

Journal:

Year:

2019

File:

PDF, 1.15 MB

2019

42

Choline PET/CT in Multiple Myeloma

Mesguich, Charles, Hulin, Cyrille, Lascaux, Axelle, Bordenave, Laurence, Marit, Gerald, HindiÃ©, Elif

Journal:

Year:

2020

File:

PDF, 1.23 MB

2020

43

Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an openâlabel Phase II study

Chari, Ajai, RodriguezâOtero, Paula, McCarthy, Helen, Suzuki, Kenshi, Hungria, Vania, Sureda Balari, Anna, Perrot, Aurore, Hulin, Cyrille, Magen, Hila, Iida, Shinsuke, Maisnar, Vladimir, Karlin, Lio

Journal:

British Journal of Haematology

Year:

2020

File:

PDF, 328 KB

2020

44

Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results

Usmani, Saad Z., Mateos, Maria-Victoria, Hungria, Vania, Iida, Shinsuke, Bahlis, Nizar J., Nahi, Hareth, Magen, Hila, Cavo, Michele, Hulin, Cyrille, White, Darrell, De Stefano, Valerio, Fastenau, John

Journal:

Journal of Cancer Research and Clinical Oncology

Year:

2020

File:

PDF, 840 KB

2020

45

Matchingâadjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patients with newly diagnosed multiple myeloma who are transplant eligible

Sonneveld, Pieter, Mateos, MarÃaâVictoria, Alegre, Adrian, Facon, Thierry, Hulin, Cyrille, Hashim, Mahmoud, Vincken, Talitha, Kampfenkel, Tobias, Cote, Sarah, He, Jianming, Lam, Annette, Moreau, Ph

Journal:

Year:

2020

File:

PDF, 493 KB

2020

46

Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma

Mesguich, Charles, Hulin, Cyrille, Latrabe, Valerie, Lascaux, Axelle, Bordenave, Laurence, HindiÃ©, Elif, Marit, Gerald

Journal:

Annals of Hematology

Year:

2020

File:

PDF, 5.45 MB

2020

47

Del17p without TP53 mutation confers poor prognosis in intensively treated newly diagnosed multiple myeloma patients.

Corre, Jill, Perrot, Aurore, Caillot, Denis, Belhadj Merzoug, Karim, Hulin, Cyrille, Leleu, Xavier, Mohty, Mohamad, Facon, Thierry, Buisson, Laure, Do Souto, Laura, Lannes, Romain, Dufrechou, Stephani

Journal:

Year:

2020

File:

PDF, 912 KB

2020

48

Three Drug Combinations in the Treatment of Fit Elderly Multiple Myeloma Patients

Gardeney, HÃ©lÃ¨ne, Bobin, Arthur, Gruchet, CÃ©cile, Sabirou, Florence, LÃ©vy, Anthony, Nsiala, Laly, Cailly, Laura, Tomowiak, CÃ©cile, Torregrosa, Jose, Moya, Niels, Hulin, Cyrille, Leleu, Xavier, Gu

Journal:

Journal of Clinical Medicine

Year:

2020

File:

PDF, 295 KB

2020

49

Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial

Perrot, Aurore, Facon, Thierry, Plesner, Torben, Usmani, Saad Z., Kumar, Shaji, Bahlis, Nizar J., Hulin, Cyrille, Orlowski, Robert Z., Nahi, Hareth, Mollee, Peter, Ramasamy, Karthik, Roussel, Murielle

Journal:

Journal of Clinical Oncology

Year:

2020

File:

PDF, 500 KB

2020